Business Wire

Cosette Pharmaceuticals Announces the Approval and Launch of Metronidazole Gel USP, 1%

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc. ("Cosette") announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated New Drug Applications (ANDA) for ...
Reuters

Mayne Pharma slumps 30% as Cosette threatens to scrap $432 million deal

May 21 (Reuters) - Mayne Pharma shares (MYX.AX), opens new tab posted their worst day in 16 years on Wednesday after U.S.-based Cosette Pharmaceuticals initiated a review of its A$672 million ($432.1 ...
PharmTech

Cosette Pharmaceuticals Adds to Dermatology and Women’s Health Portfolio with Mayne Pharma Purchase

While the boards of directors of both companies have approved the transaction, it is not expected to close until the second quarter of 2025, as Mayne Pharma’s shareholders must still vote in favor of ...
The Australian Financial Review

Mayne shares rally on bid approval hopes as FIRB delays its ruling

The Foreign Investment Review Board has extended its deadline for ruling on US healthcare giant Cosette’s $672 million bid for Mayne Pharma as shares in the target rallied on hopes that Treasurer Jim ...